We’re on a mission to accelerate global drug launches.
Every pharmaceutical drug launch is a uniquely complex endeavour. Before patients can access novel treatments, pharmaceutical manufacturers need to carefully analyze gigabytes of messy, fragmented data, create thousands of pages of regulatory documents, determine global launch sequences, and so much more. Historically, this complexity has inevitably resulted in multiple years of necessary preparation.
Our mission is to accelerate global pharmaceutical drug launches. By automating repetitive workflows on top of our robust data foundation, we help pharmaceutical companies bring life-saving treatments to patients faster than ever before.
Founders
Cellbyte founders Felix Steinbrenner, Daniel Moreira and Samuel Moreira
Felix Steinbrenner
Co-CEO
Daniel Moreira
Co-CEO
Samuel Moreira
CTO
Advisors
Stefan Kilian
Former Corporate Vice President Market Access, Pricing and HEOR
Boehringer Ingelheim
Troy Dale
Former Head Commercial, Strategic Partnerships Unit (VP)
Novartis
Romain Marcel
Former General Manager, EMEA CP&C
Veeva Systems
Backed by world-class investors
Y Combinator Frontline Ventures Pace Ventures
Saras Capital
Springboard Health.
Angels
Newsroom
Press releases and partnership announcements
Raising $2.75M from Frontline Ventures Nov 18, 2025
Startup in spotlight: Cellbyte zips $2.75M to cut pharma drug launch times Nov 18, 2025